22h
Compass Pathways Highlights Phase 3 COMP360 TRD Gains, 26-Week Durability and FDA Path at Conference
Executives from Compass Pathways (NASDAQ:CMPS) discussed recent Phase 3 results for its COMP360 psilocybin program in treatment-resistant depression (TRD), highlighting statistically significant ...
AbbVie’s foray into the obesity space is successful so far, analysts agree, as amylin analog ABBV-295 elicited as much as 9.73% weight loss at 13 weeks in the multiple ascending dose portion of a ...
Trade ministers from 166 nations will convene in Yaounde, Cameroon, from March 26-29, 2026, for the 14th WTO Ministerial Conference. Key discussions will revolve around WTO reforms, agriculture, ...
The Middle East war rages on as Israel and the US bombard Iran, that has retaliated with strikes on Israel and the Gulf, with ...
The UT and the MC spent months in a blame game over jurisdiction, with the MC citing a severe fund crunch and the UT claiming the roads weren’t its responsibility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results